Aspen Pharmacre Hl ADR (APNHY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 06/30
(Values in U.S. thousands)
| 06-2025 | 06-2024 | 06-2023 | 06-2022 | 06-2021 | |
| Sales | 2,389,301 | 2,391,771 | 2,295,988 | 2,540,275 | 2,462,343 |
| Cost of Goods | 1,335,293 | 1,350,982 | 1,228,110 | 1,335,740 | 1,302,500 |
| Gross Profit | 1,054,008 | 1,040,789 | 1,067,878 | 1,204,535 | 1,159,843 |
| Operating Expenses | 975,123 | 667,378 | 626,827 | 634,723 | 699,248 |
| Operating Income | 79,179 | 374,393 | 441,161 | 570,552 | 461,094 |
| Interest Expense | 105,682 | 125,351 | 101,294 | 42,244 | 79,740 |
| Other Income | 19,726 | 56,657 | 29,836 | 6,909 | 9,128 |
| Pre-tax Income | -6,777 | 305,699 | 369,702 | 535,217 | 390,483 |
| Income Tax | 52,896 | 70,085 | 74,843 | 108,307 | 77,653 |
| Net Income Continuous | -59,673 | 235,614 | 294,859 | 426,910 | 312,830 |
| Net Income Discontinuous | N/A | N/A | N/A | N/A | 522 |
| Net Income | $-59,673 | $235,614 | $294,859 | $426,910 | $313,351 |
| EPS Basic Total Ops | -0.13 | 0.53 | 0.66 | 0.94 | 0.69 |
| EPS Basic Continuous Ops | -0.13 | 0.53 | 0.66 | 0.94 | 0.69 |
| EPS Diluted Total Ops | -0.13 | 0.53 | 0.66 | 0.94 | 0.69 |
| EPS Diluted Continuous Ops | -0.13 | 0.53 | 0.66 | 0.94 | 0.69 |
| EPS Diluted Before Non-Recurring Items | 0.58 | 0.80 | 0.84 | 1.07 | 0.79 |
| EBITDA(a) | $194,283 | $479,949 | $542,004 | $683,267 | $568,870 |